LT3566712T - Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai - Google Patents

Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai

Info

Publication number
LT3566712T
LT3566712T LTEP19164277.6T LT19164277T LT3566712T LT 3566712 T LT3566712 T LT 3566712T LT 19164277 T LT19164277 T LT 19164277T LT 3566712 T LT3566712 T LT 3566712T
Authority
LT
Lithuania
Prior art keywords
composition
ovarian stimulation
controlled ovarian
controlled
stimulation
Prior art date
Application number
LTEP19164277.6T
Other languages
English (en)
Inventor
Joan-Carles Arce
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46785372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3566712(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of LT3566712T publication Critical patent/LT3566712T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
LTEP19164277.6T 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai LT3566712T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11176803 2011-08-08

Publications (1)

Publication Number Publication Date
LT3566712T true LT3566712T (lt) 2021-03-10

Family

ID=46785372

Family Applications (7)

Application Number Title Priority Date Filing Date
LTEP20186935.1T LT3756681T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP19213649.7T LT3646881T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP21207717.6T LT4005588T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP17154031.3T LT3195875T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP19164277.6T LT3566712T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP14184409.2T LT2821080T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP18167552.1T LT3395357T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai

Family Applications Before (4)

Application Number Title Priority Date Filing Date
LTEP20186935.1T LT3756681T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP19213649.7T LT3646881T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP21207717.6T LT4005588T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP17154031.3T LT3195875T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai

Family Applications After (2)

Application Number Title Priority Date Filing Date
LTEP14184409.2T LT2821080T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai
LTEP18167552.1T LT3395357T (lt) 2011-08-08 2012-08-08 Kompozicija, skirta kontroliuojamai kiaušidžių stimuliacijai

Country Status (31)

Country Link
US (4) US9694052B2 (lt)
EP (9) EP4306174A3 (lt)
JP (5) JP6161609B2 (lt)
KR (7) KR20230024442A (lt)
CN (2) CN107281470A (lt)
AR (1) AR087476A1 (lt)
AU (3) AU2012293647B2 (lt)
BR (2) BR122020001644B1 (lt)
CA (1) CA2844282A1 (lt)
CY (1) CY1117214T1 (lt)
DK (8) DK4005588T3 (lt)
ES (7) ES2950911T3 (lt)
FI (1) FI3756681T3 (lt)
HK (2) HK1198005A1 (lt)
HR (7) HRP20230607T1 (lt)
HU (7) HUE027674T2 (lt)
IL (2) IL300380A (lt)
JO (1) JO3092B1 (lt)
LT (7) LT3756681T (lt)
MX (2) MX348981B (lt)
PL (7) PL3195875T3 (lt)
PT (5) PT3756681T (lt)
RS (7) RS59107B1 (lt)
RU (2) RU2613324C3 (lt)
SA (1) SA112330762B1 (lt)
SI (7) SI2741763T1 (lt)
SM (1) SMT201600038B (lt)
TR (2) TR201900071T4 (lt)
TW (2) TWI555530B (lt)
WO (1) WO2013020996A1 (lt)
ZA (2) ZA201400952B (lt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI604850B (zh) * 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
EP3237608B1 (en) * 2014-12-22 2019-10-09 F. Hoffmann-La Roche AG Cmp-dependent sialidase activity
CA2975444A1 (en) * 2015-04-17 2016-10-20 Ferring B.V. Composition for treatment of infertility
WO2016207353A1 (en) 2015-06-26 2016-12-29 Ferring B.V. Methods of purification and/or viral inactivation
AU2016323541A1 (en) * 2015-09-17 2018-04-12 Glycotope Gmbh Mammalian follicle-stimulating hormone composition with increased stability
IL265696B1 (en) 2016-09-30 2024-04-01 Sumitomo Pharma Switzerland Gmbh -(n-acetyl-d-tyrosyl-trans-4-hydroxy-l-propyl-l-asparaginyl-l-threonyl-l-phenylalenyl) hydrazinocarbonyl-l-leucyl-nω-methyl-l-arginyl-l-tryptophanamide for use in assisted reproductive technology.
EP3675894B1 (en) 2017-09-01 2021-11-03 Ferring B.V. Composition for controlled ovarian stimulation
WO2019211153A1 (en) 2018-04-30 2019-11-07 Ferring B.V. Composition for controlled ovarian stimulation
TW202027780A (zh) 2018-10-17 2020-08-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
CN110841060A (zh) * 2019-11-21 2020-02-28 上海交通大学 Choriogonadotropin alfa在治疗多囊卵巢综合征中的应用
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
WO2023186331A1 (en) 2022-04-01 2023-10-05 Ferring B.V. Mixed protocol for treatment of infertility
WO2023227761A1 (en) 2022-05-26 2023-11-30 Ferring B.V. Compositions and methods for treatment of infertility in males
WO2024008971A1 (en) 2022-07-08 2024-01-11 Ferring B.V. Compositions and methods for intrauterine insemination (iui)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW518235B (en) 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
EP1074265A1 (en) * 1999-08-03 2001-02-07 Erasmus Universiteit Rotterdam Use of AMH and/or AMH agonists and/or AMH antagonists for long-term control of female fertility
DK1438336T3 (da) * 2001-10-22 2006-10-02 Applied Research Systems Gonadotropiner til follikeldannelse
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US8501719B2 (en) * 2005-11-08 2013-08-06 American Infertility Of New York Androgen treatment in females
TWI488640B (zh) * 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI604850B (zh) * 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
HUE025514T2 (en) * 2010-09-29 2016-02-29 Ferring Bv Preparation for use in treating infertility
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض

Also Published As

Publication number Publication date
CY1117214T1 (el) 2017-04-05
RS61672B1 (sr) 2021-04-29
AU2016273925B2 (en) 2018-03-15
LT4005588T (lt) 2024-03-25
WO2013020996A1 (en) 2013-02-14
RU2739037C2 (ru) 2020-12-21
JP2020147600A (ja) 2020-09-17
KR20190100449A (ko) 2019-08-28
US11291708B2 (en) 2022-04-05
CN107281470A (zh) 2017-10-24
US20200345814A1 (en) 2020-11-05
US10624953B2 (en) 2020-04-21
AU2012293647A1 (en) 2014-02-27
RS61843B1 (sr) 2021-06-30
PT3756681T (pt) 2023-07-25
AR087476A1 (es) 2014-03-26
PT3395357T (pt) 2019-08-27
PL3566712T3 (pl) 2021-07-12
SI3566712T1 (sl) 2021-04-30
MX2020010991A (es) 2020-11-09
HRP20181639T1 (hr) 2018-12-14
KR20230024442A (ko) 2023-02-20
BR122020001644B1 (pt) 2022-08-02
PL2821080T3 (pl) 2019-04-30
HRP20191437T1 (hr) 2019-11-15
SI3395357T1 (sl) 2019-09-30
LT2821080T (lt) 2019-01-10
SI2821080T1 (sl) 2019-01-31
DK3756681T3 (da) 2023-07-31
HUE053716T2 (hu) 2021-07-28
JP2019077693A (ja) 2019-05-23
KR20210143934A (ko) 2021-11-29
EP2821080A1 (en) 2015-01-07
SI3646881T1 (sl) 2021-08-31
JP2023134561A (ja) 2023-09-27
LT3756681T (lt) 2023-07-25
PT3195875T (pt) 2018-10-31
JP7309660B2 (ja) 2023-07-18
ES2562648T3 (es) 2016-03-07
EP2741763A1 (en) 2014-06-18
EP2821080B1 (en) 2018-10-10
PL3756681T3 (pl) 2023-08-21
TW201309322A (zh) 2013-03-01
ES2742163T3 (es) 2020-02-13
FI3756681T3 (fi) 2023-07-28
DK3566712T3 (da) 2021-04-19
EP3395357A1 (en) 2018-10-31
EP3195875B1 (en) 2018-07-25
AU2018203222A1 (en) 2018-05-24
MX348981B (es) 2017-07-06
LT3195875T (lt) 2018-11-12
KR102111514B1 (ko) 2020-05-18
TWI555530B (zh) 2016-11-01
KR20190140098A (ko) 2019-12-18
PL2741763T3 (pl) 2016-07-29
TWI657822B (zh) 2019-05-01
RS58198B1 (sr) 2019-03-29
DK3395357T3 (da) 2019-08-19
JP2014522871A (ja) 2014-09-08
EP4306174A3 (en) 2024-04-10
HRP20210722T1 (hr) 2021-06-11
EP3195875A1 (en) 2017-07-26
CA2844282A1 (en) 2013-02-14
JP6500050B2 (ja) 2019-04-10
US20180028620A1 (en) 2018-02-01
HK1198005A1 (zh) 2015-03-06
SI3756681T1 (sl) 2023-08-31
RU2017106756A (ru) 2019-01-23
EP3395357B1 (en) 2019-05-15
PL3195875T3 (pl) 2019-01-31
CN103732243A (zh) 2014-04-16
DK4005588T3 (da) 2024-04-29
HRP20210277T1 (hr) 2021-04-02
KR20210099162A (ko) 2021-08-11
TW201716082A (zh) 2017-05-16
KR102499969B1 (ko) 2023-02-14
KR102014469B1 (ko) 2019-08-26
HUE062640T2 (hu) 2023-11-28
DK2741763T3 (da) 2016-02-15
EP3756681A1 (en) 2020-12-30
HUE040058T2 (hu) 2019-02-28
HUE044610T2 (hu) 2019-11-28
SI3195875T1 (sl) 2018-11-30
LT3395357T (lt) 2019-08-26
BR112014002884A2 (pt) 2017-02-21
RU2613324C2 (ru) 2017-03-15
PT3646881T (pt) 2021-06-02
HRP20230607T1 (hr) 2023-09-29
RS57897B1 (sr) 2019-01-31
HUE054312T2 (hu) 2021-08-30
KR20200121918A (ko) 2020-10-26
SMT201600038B (it) 2016-02-25
PL3646881T3 (pl) 2021-11-02
ZA201400952B (en) 2022-03-30
IL300380A (en) 2023-04-01
EP2741763B1 (en) 2015-11-18
EP3646881A1 (en) 2020-05-06
JP6718951B2 (ja) 2020-07-08
RS54561B1 (en) 2016-06-30
JP6161609B2 (ja) 2017-07-12
EP4005588A1 (en) 2022-06-01
ES2950911T3 (es) 2023-10-16
AU2012293647B2 (en) 2016-10-06
SA112330762B1 (ar) 2015-10-08
DK3646881T3 (da) 2021-07-26
RU2613324C3 (ru) 2021-06-09
RS64328B1 (sr) 2023-08-31
RU2739037C3 (ru) 2021-09-08
PT2821080T (pt) 2018-12-17
IL230696B2 (en) 2023-07-01
IL230696B1 (en) 2023-03-01
ES2704878T3 (es) 2019-03-20
IL230696A0 (en) 2014-03-31
KR20140054191A (ko) 2014-05-08
KR102353144B1 (ko) 2022-01-18
ES2692774T3 (es) 2018-12-05
US20220370567A1 (en) 2022-11-24
DK2821080T3 (en) 2019-01-28
NZ620369A (en) 2015-12-24
HUE041769T2 (hu) 2019-05-28
EP3566712A1 (en) 2019-11-13
DK3195875T3 (en) 2018-11-12
JP2017141253A (ja) 2017-08-17
EP3566712B1 (en) 2021-01-27
ES2884947T3 (es) 2021-12-13
MX2014001489A (es) 2014-04-25
EP3756681B1 (en) 2023-05-03
ES2871405T3 (es) 2021-10-28
LT3646881T (lt) 2021-05-25
RU2014102924A (ru) 2015-09-20
US20140329748A1 (en) 2014-11-06
HRP20190023T1 (hr) 2019-02-22
HUE027674T2 (en) 2016-11-28
RS59107B1 (sr) 2019-09-30
TR201900071T4 (tr) 2019-01-21
TR201911269T4 (tr) 2019-08-21
ZA201506382B (en) 2017-01-25
PL3395357T3 (pl) 2019-11-29
HRP20160145T1 (hr) 2016-04-08
HK1204923A1 (en) 2015-12-11
AU2018203222B2 (en) 2020-03-12
EP3646881B1 (en) 2021-04-28
EP4306174A2 (en) 2024-01-17
AU2016273925A1 (en) 2017-01-12
JO3092B1 (ar) 2017-03-15
RU2017106756A3 (lt) 2020-07-09
SI2741763T1 (sl) 2016-02-29
EP4005588B1 (en) 2024-02-07
US9694052B2 (en) 2017-07-04

Similar Documents

Publication Publication Date Title
HRP20190023T1 (hr) Pripravak za kontroliranu stimulaciju jajnika
HK1206626A1 (en) Composition for controlled ovarian stimulation
PT3566712T (pt) Composição para estimulação controlada do ovário